Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$4.13 0.05 (1.23%)
2/9/2010 4:01 PM

AMERICAN ORIENTL BIO (AOB)

CAPS Rating:
*****

The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AOB

Add Stock to Watchlist

What the Community Thinks

Total Members

3033 Outperforms
89 Underperforms
 

All-Stars

928 Outperforms
28 Underperforms
 

Wall Street

4 Outperforms
1 Underperforms
 

Members bullish on AOB are also bullish on:

Members bearish on AOB are also bearish on:

Ticker Tags

Personal Products (35), Consumer Staples (230), Drug Manufacturers - Major (4), International Stock (684), Nutraceuticals (2), Value (1901), Defensive (1457), China (251), Micro Cap (4701)
Suggest a tag

AMERICAN ORIENTL BIO At A Glance

Current Price: $4.13
Last Trade Time: 2/9/2010 4:01 PM
Open: $4.13
Previous Close: $4.08
Daily Range: $4.04 - $4.16
52-Week Range: $3.29 - $6.38
Volume: 769,495
Market Cap: $323.47M
P/E Ratio: 8.00
Compare Our Special Broker Offers!

Stock Trends

AOB VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

12

AMERICAN ORIENTL BIO (AOB)

Avatar mrindependent (99.29) Submitted: 10/01/09 5:39 PM

According to Jubak, the Chinese government is making a substantial push to expand the country's healthcare sector. American Oriental Biology ought to benefit from this initiative. The price is right at 1.04 times book value and 6 times estimated earnings in 2010 (i.e. $0.77 per share). The balanc...More

Replies: 6 | Reply | Permalink

Top Bear Pitch

Recs

1

AMERICAN ORIENTL BIO (AOB)

Avatar zotten (89.68) Submitted: 11/13/09 9:15 PM

I suggest people read the following blog:

http://seekingalpha.com/article/172921-american-oriental-bioengineering-questionable-acquisitions

I do not like what I read. I will stay clear.

Replies: 2 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 473 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (AOB)

Avatar whack47 (< 20) Submitted: 2/08/10 9:39 PM : Outperform Start Price: $4.13 AOB Score: -0.08

hahahahahahahahahahahahahahahahahahahahahahaha Going with the crowd HA!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AOB)

Avatar alabama4606 (55.98) Submitted: 2/05/10 9:11 AM : Outperform Start Price: $4.20 AOB Score: -2.29

P/E, P/Free Cash Flow, P/Book, EPS growth, all scream buy to me.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (AOB)

Avatar marketprofile01 (45.16) Submitted: 2/04/10 5:53 AM : Outperform Start Price: $4.22 AOB Score: -0.52

Cash flows from operations for AOB: Note: all figures obtained from Reuters ProVestor Plus Company Report
2001: $1,015,000
2002: $2,021,000
2003: $2,530,000
2004: $8,326,000
2005: $11,401,000
2006: $29,093,000
2007: $45,100,000
2008: $77,757,000
2009: $44,325,000* First 9 months of fiscal year 2009
Total cash flows Generated since 2001: $221,478,000
i wait and see in wich way management works with this cash..

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AOB)

Avatar sjacobs26 (< 20) Submitted: 2/03/10 12:30 AM : Outperform Start Price: $4.28 AOB Score: -1.08

China, healthcare, weak dollar! I own in real life and will add to position under $4.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (AOB)

Avatar noirblood (64.06) Submitted: 1/27/10 4:20 PM : Outperform Start Price: $4.07 AOB Score: 4.17

Low P/E (8.4) given potential growth. 12.8% net profit margins, 66% 5-year revenue growth, 33% 5-year EPS growth, and its -7% below its price one year ago.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 473 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBreanMurray 86.47 11/30/09 Outperform NS $3.92+5.36%-2.11%+7.47
TrackMerriman < 20 01/12/09 Outperform NS $5.29-21.93%+22.82%-44.75
TrackRothCapital 80.39 12/30/08 Outperform NS $6.34-34.86%+24.26%-59.11
TrackJefferies 82.08 11/21/07 Outperform NS $10.65-61.22%-21.49%-39.73
TrackJimCramer < 20 06/06/06 Underperform 3W $5.52-25.18%-9.65%+15.53

Results 1 - 5 of 5  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 281ms